Genetic risk factors for chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Genetics
• Molecular Biology

Background:

• Cigarette smoking is the primary risk factor for chronic obstructive pulmonary disease (COPD).
• Only a subset of smokers develop symptomatic COPD, suggesting other contributing factors.
• Family and twin studies indicate a significant role for genetic predisposition in COPD etiology.

Purpose of the Study:

• To conduct a comprehensive literature review of genes investigated as potential risk factors for COPD.
• To consolidate current knowledge on the genetic underpinnings of COPD development.
• To explore the relevance of COPD genetic research to other inflammatory diseases.

Main Methods:

• Systematic literature search for genetic association studies related to COPD.
• Review and synthesis of findings on various candidate genes and their variants.
• Analysis of established and potential genetic risk factors for COPD.

Main Results:

• Homozygosity for the Z allele of the alpha1-antitrypsin gene is the sole established genetic risk factor for COPD.
• Alpha1-antitrypsin gene heterozygotes and other mutations affecting its structure or regulation are also implicated.
• Genes such as alpha1-antichymotrypsin, alpha2-macroglobulin, vitamin D-binding protein, and blood group antigens are associated with COPD risk.
• Cystic fibrosis transmembrane regulator gene variants are linked to disseminated bronchiectasis.

Conclusions:

• The genetic basis of COPD is increasingly understood, with multiple genes likely contributing to its pathogenesis.
• Alpha-1 antitrypsin deficiency remains a key genetic factor in COPD.
• Further research into COPD genetics may offer insights into other inflammatory conditions.